Skip to main content
. 2019 Oct 17;7:e7815. doi: 10.7717/peerj.7815

Figure 4. Rosiglitazone administration improved BM-EPC function in db/db diabetic mice.

Figure 4

In db/db mice, BM-EPCs were isolated and cultured after 4 weeks RSG therapy. BM-EPC function was estimated by tube formation assay and migration assay. RSG treatment elevated tube formation ability (A–D, I) and migration ability (E–H, J) of BM-EPCs. (A) 50×; scale bar, 100 µm; B: 100×; scale bar, 100 µm. Values are mean ± SEM, (n = 6 per group). ∗P < 0.05 vs. Control; #P < 0.05 vs. db/db. RSG, rosiglitazone. lpf, low power field.